Antelope Dx is a spin-off company from Ugent (Belgium) and immunodiagnostics company Mycartis. Antelope Dx develops a diagnostic solution for home and other decentralized settings that brings lab quality analysis with the ease-of-use of a pregnancy test at a consumer price tag. The first test is a “Sexually Transmitted Diseases (STD) urine self-test”, as an aid in diagnosis of the 2 most prevalent STD’s Chlamydia trachomatis and Neisseria gonorrhoea. Follow-on tests will include the “Flu A/B test", and quantitative blood-based tests. The latter tests are relevant additions to the test menu to start monitoring chronic patients .